Sign Up to like & get
recommendations!
0
Published in 2018 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.10.019
Abstract: CTLA-4: cytotoxic T-lymphocyteeassociated protein 4 PD-1: Programmed cell death protein
read more here.
Keywords:
regression pigmented;
lesions patient;
pigmented lesions;
metastatic melanoma ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14678
Abstract: Pembrolizumab(®) , a first line immune checkpoint inhibitor, has shown good clinical activity with an acceptable safety profile, in the management of metastatic melanoma.(1, 2) We report a patient with metastatic melanoma, treated with anti-PD-1,…
read more here.
Keywords:
melanoma;
regression;
treated anti;
metastatic melanoma ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2019-000380
Abstract: Background The combination of the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab is a mainstay of treatment for selected patients with metastatic melanoma. This combination also results in more frequent immune-related adverse events (irAEs) than…
read more here.
Keywords:
immune related;
case;
metastatic melanoma;
melanoma treated ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.9510
Abstract: 9510 Background: There are no validated blood-based biomarkers to monitor efficacy in pts with advanced melanoma. Lactate dehydrogenase (LDH) is an established prognostic factor; however, it is not normally used to inform treatment decisions. ctDNA…
read more here.
Keywords:
ctdna;
metastatic melanoma;
melanoma treated;
unresectable metastatic ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.10029
Abstract: 10029Background: This is the first randomized trial testing the addition of an oncolytic virus to an immune checkpoint inhibitor for advanced melanoma. At the 3-year (yr) follow-up, the combination...
read more here.
Keywords:
advanced melanoma;
association complete;
response survival;
survival advanced ... See more keywords
Photo from archive.org
Sign Up to like & get
recommendations!
0
Published in 2017 at "International Journal of Approximate Reasoning"
DOI: 10.21474/ijar01/3268
Abstract: Divyesh Kumar 1 , Anindya Mukherjee 1 , Manish Rohilla 2 , Nalini Gupta 2 , Bhavana Rai 1 and Sushmita Ghoshal 1 . 1. Department of Radiotherapy, PGIMER, Chandigarh. 2. Department of Cytopathology, PGIMER,…
read more here.
Keywords:
carcinoma cervix;
treated patient;
melanoma treated;
malignant melanoma ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Acta dermato-venereologica"
DOI: 10.2340/00015555-3355
Abstract: Journal Compilation © 2020 Acta Dermato-Venereologica. doi: 10.2340/00015555-3355 Immune checkpoint inhibitors (ICIs) and kinase inhibitors (BRAF and MEK inhibitors) have improved clinical outcomes in patients with advanced BRAFV600 mutant melanoma. Preliminary results from ongoing, phase…
read more here.
Keywords:
melanoma;
hair depigmentation;
hair;
hair loss ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Contemporary Brachytherapy"
DOI: 10.5114/jcb.2022.115379
Abstract: Purpose The aim of this study was to demonstrate that uveal melanoma (UM) treated with eye plaque brachytherapy (EPB) with intra-operative ultrasound (IOUS) guidance results in increased local control. Material and methods A retrospective study…
read more here.
Keywords:
year;
intra operative;
brachytherapy;
operative ultrasound ... See more keywords